Skip to main content
PMC home page
Journal of Bacteriology logoLink to Journal of Bacteriology
. 1968 Mar;95(3):919–924. doi: 10.1128/jb.95.3.919-924.1968

In Vivo–produced Anthrax Toxin

Donald C Fish 1, Ralph E Lincoln 1
PMCID: PMC252110  PMID: 4966834

Abstract

Specific anthrax antigens were demonstrated in the blood of animals dying from anthrax. These antigens, which appear in the blood at the time when organisms are first detected and whose concentration continues to increase as the number of organisms increases, do not elicit a strong antibody response. The in vivo-produced toxin differs from the in vitro in killing more rapidly and being more difficult to detect. The in vivo toxin exists as an aggregate whose biological and serological activity depends upon its particular composition or configuration, or both.

Full text

PDF
921

Images in this article

920Image
on p.920
922Image
on p.922

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BEALL F. A., TAYLOR M. J., THORNE C. B. Rapid lethal effect in rats of a third component found upon fractionating the toxin of Bacillus anthracis. J Bacteriol. 1962 Jun;83:1274–1280. doi: 10.1128/jb.83.6.1274-1280.1962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BELTON F. C., HENDERSON D. W. A method for assaying anthrax immunising antigen and antibody. Br J Exp Pathol. 1956 Apr;37(2):156–160. [PMC free article] [PubMed] [Google Scholar]
  3. Fish D. C., Lincoln R. E. Biochemical and biophysical characterization of anthrax toxin. Fed Proc. 1967 Sep;26(5):1534–1538. [PubMed] [Google Scholar]
  4. Fish D. C., Mahlandt B. G., Dobbs J. P., Lincoln R. E. Purification and properties of in vitro-produced anthrax toxin components. J Bacteriol. 1968 Mar;95(3):907–918. doi: 10.1128/jb.95.3.907-918.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. HAINES B. W., KLEIN F., LINCOLN R. E. QUANTITATIVE ASSAY FOR CRUDE ANTHRAX TOXINS. J Bacteriol. 1965 Jan;89:74–83. doi: 10.1128/jb.89.1.74-83.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. HODGES D. R., RHIAN M. A. Surgical procedure for cannulation of theoracic and right lymphatic ducts of rehusus monkeys for survival experimentation. Exp Med Surg. 1962;20:258–266. [PubMed] [Google Scholar]
  7. KLEIN F., DEARMON I. A., Jr, LINCOLN R. E., MAHLANDT B. G., FERNELIUS A. L. Immunological studies of anthrox. II. Levels of immunity against Bacillus anthracis obtained with protective antigen and live vaccine. J Immunol. 1962 Jan;88:15–19. [PubMed] [Google Scholar]
  8. Klein F., Walker J. S., Fitzpatrick D. F., Lincoln R. E., Mahlandt B. G., Jones W. I., Jr, Dobbs J. P., Hendrix K. J. Pathophysiology of anthrax. J Infect Dis. 1966 Apr;116(2):123–138. doi: 10.1093/infdis/116.2.123. [DOI] [PubMed] [Google Scholar]
  9. MOLNAR D. M., ALTENBERN R. A. ALTERATIONS IN THE BIOLOGICAL ACTIVITY OF PROTECTIVE ANTIGEN OF BACILLUS ANTHRACIS TOXIN. Proc Soc Exp Biol Med. 1963 Nov;114:294–297. [PubMed] [Google Scholar]
  10. Mahlandt B. G., Klein F., Lincoln R. E., Haines B. W., Jones W. I., Jr, Friedman R. H. Immunologic studies of anthrax. IV. Evaluation of the immunogenicity of three components of anthrax toxin. J Immunol. 1966 Apr;96(4):727–733. doi: 10.21236/ad0640357. [DOI] [PubMed] [Google Scholar]
  11. SARGEANT K., STANLEY J. L., SMITH H. The serological relationship between purified preparations of factors I and II of the anthrax toxin produced in vivo and in vitro. J Gen Microbiol. 1960 Feb;22:219–228. doi: 10.1099/00221287-22-1-219. [DOI] [PubMed] [Google Scholar]
  12. SMITH H., GALLOP R. C. The chemical basis of the virulence of Bacillus anthracis. VI. An extracellular immunising aggressin isolated from exudates of infected guinea-pigs. Br J Exp Pathol. 1956 Apr;37(2):144–155. [PMC free article] [PubMed] [Google Scholar]
  13. SMITH H., KEPPIE J., STANLEY J. L. The chemical basis of the virulence of Bacillus anthracis. V. The specific toxin produced by B. Anthracis in vivo. Br J Exp Pathol. 1955 Oct;36(5):460–472. [PMC free article] [PubMed] [Google Scholar]
  14. SMITH H., TEMPEST D. W., STANLEY J. L., HARRIS-SMITH P. W., GALLOP R. C. The chemical basis of the virulence of Bacillus anthracis. VII. Two components of the anthrax toxin: their relationship to known immunising aggressins. Br J Exp Pathol. 1956 Jun;37(3):263–271. [PMC free article] [PubMed] [Google Scholar]
  15. STANLEY J. L., SARGEANT K., SMITH H. Purification of factors I and II of the anthrax toxin produced in vivo. J Gen Microbiol. 1960 Feb;22:206–218. doi: 10.1099/00221287-22-1-206. [DOI] [PubMed] [Google Scholar]
  16. STANLEY J. L., SMITH H. Purification of factor I and recognition of a third factor of the anthrax toxin. J Gen Microbiol. 1961 Sep;26:49–63. doi: 10.1099/00221287-26-1-49. [DOI] [PubMed] [Google Scholar]
  17. STRANGE R. E., THORNE C. B. Further purification studies on the protective antigen of Bacillus anthracis produced in vitro. J Bacteriol. 1958 Aug;76(2):192–202. doi: 10.1128/jb.76.2.192-202.1958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. TEMPEST D. W., SMITH H. The effect of metabolite analogues on growth of Bacillus anthracis in the guinea pig and on the formation of virulence-determining factors. J Gen Microbiol. 1957 Dec;17(3):739–749. doi: 10.1099/00221287-17-3-739. [DOI] [PubMed] [Google Scholar]
  19. THORNE C. B., BELTON F. C. An agar-diffusion method for titrating Bacillus anthracis immunizing antigen and its application to a study of antigen production. J Gen Microbiol. 1957 Oct;17(2):505–516. doi: 10.1099/00221287-17-2-505. [DOI] [PubMed] [Google Scholar]
  20. WARD M. K., MCGANN V. G., HOGGE A. L., Jr, HUFF M. L., KANODE R. G., Jr, ROBERTS E. O. STUDIES ON ANTHRAX INFECTIONS IN IMMUNIZED GUINEA PIGS. J Infect Dis. 1965 Feb;115:59–67. doi: 10.1093/infdis/115.1.59. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Bacteriology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES